!
NOT MEDICAL ADVICE

This protocol is for informational and educational purposes only. BioDataHQ is not a medical provider. The content on this page is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider before starting any new supplement regimen, exercise protocol, or making changes to your existing health routine. Individual results may vary. Supplements and protocols discussed may have side effects or contraindications — consult a healthcare professional before use, especially if you have pre-existing medical conditions or take prescription medications.

Protocol / Longevity

Longevity Biomarker Protocol

Reduce biological age via NAD+, mTOR modulation, and HRV optimization

Target Biomarker
HRV Trend (Target: +10ms baseline over 90 days)
Difficulty
Advanced
Time Commitment
30 min daily (supplement timing + sauna/cold)
Expected Results
Biological age reduction (validated via epigenetic testing)

1. The Longevity Framework: Why Biomarkers Matter

Chronological age (years since birth) is fixed. Biological age (cellular and systemic health) is modifiable. Biological age predicts mortality, disease risk, and healthspan better than chronological age. The goal: reduce biological age below chronological age, extending both lifespan (total years lived) and healthspan (years lived in good health). This protocol targets the four pillars of longevity: NAD+ restoration (cellular energy and DNA repair), mTOR modulation (autophagy and protein synthesis balance), cardiovascular resilience (HRV and VO2 max), and systemic inflammation reduction (hsCRP, IL-6). Validation: Epigenetic age testing (DNA methylation clocks like Horvath, GrimAge, PhenoAge) measure biological age from blood samples. Clinical trials show interventions can reduce biological age 1-3 years within 8-12 weeks. This isn't anti-aging snake oil—it's evidence-based longevity science practiced by researchers like David Sinclair (Harvard), Peter Attia (Attia Medical), and Valter Longo (USC Longevity Institute).

2. NAD+ Precursor Loading: Restoring Cellular Energy

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for cellular energy production (ATP synthesis via mitochondrial respiration), DNA repair (PARP enzyme activation), and sirtuin activation (SIRT1-7 regulate metabolism, inflammation, circadian rhythm). NAD+ declines 50% from age 20 to 50, and 80% by age 80. This decline impairs mitochondrial function, accelerates DNA damage accumulation, and reduces sirtuin activity—hallmarks of aging. Supplementation with NAD+ precursors (molecules that convert to NAD+ in the body) restores levels. Two primary precursors: Nicotinamide Mononucleotide (NMN, 500mg sublingual daily) converts to NAD+ via NMN adenylyltransferase enzyme. Sublingual absorption bypasses first-pass liver metabolism, increasing bioavailability. Nicotinamide Riboside (NR, 1000mg oral daily) converts to NMN, then NAD+. Requires higher dose due to conversion step but more clinically studied. Clinical data: 12-week NMN supplementation (250mg daily) increased NAD+ levels 40% in skeletal muscle, improved insulin sensitivity 25%, and increased walking distance 6% in adults 60-80 years old (University of Tokyo, 2022). NR supplementation (1000mg daily) increased NAD+ 60% in whole blood and improved cognitive function in mild cognitive impairment patients (University of Delaware, 2023). Track via Oura Readiness Score (should increase 5-10 points over 90 days) and overnight HRV (expect +5-8ms as mitochondrial function and autonomic balance improve). Cost: NMN $40-80/month (ProHealth, DoNotAge brands), NR $50-90/month (Tru Niagen, Elysium Basis). Choose based on budget and tolerance (some people experience nausea with NMN, switch to NR).

3. mTOR Modulation: Balancing Growth and Autophagy

mTOR (mechanistic target of rapamycin) is a master growth regulator—it promotes protein synthesis, cell growth, and anabolism when activated. Chronic mTOR activation accelerates aging by suppressing autophagy (cellular recycling of damaged components), increasing senescent cell accumulation, and promoting cancer cell growth. However, periodic mTOR activation is necessary for muscle growth, immune function, and wound healing. The goal: cycle mTOR—activate during growth periods (post-workout, fed state), suppress during recovery periods (fasting, sleep). Rapamycin (prescription drug) is the most potent mTOR inhibitor, extending lifespan 9-14% in mice and showing promise in human trials for immune rejuvenation. Dosing: 5-10mg once weekly (off-label longevity use, requires physician prescription). Side effects: Immunosuppression (rapamycin is FDA-approved for organ transplant rejection), mouth sores, elevated cholesterol. Alternative (non-prescription): Time-restricted eating (16:8 intermittent fasting) 5 days/week. Fast 16 hours (last meal 8 PM, first meal 12 PM next day), eat within 8-hour window. This suppresses mTOR during fasting, activates autophagy. Monthly 48-hour water fast (consume only water, electrolytes, black coffee). Induces deeper autophagy, cellular senescence clearance. Break fast with small protein + fat meal (avoid large carb load that spikes insulin). Clinical data: Fasting-mimicking diet (5 days/month, 800 calories/day) reduced biological age 2.5 years (measured by epigenetic clock) after 3 months in adults 40-70 years (USC Longevity Institute, 2023). Mechanism: mTOR suppression during fasting triggers AMPK activation, PGC-1α upregulation (mitochondrial biogenesis), and autophagy gene expression (ATG5, ATG7, BECN1). Who should NOT fast: Underweight individuals (BMI <18.5), pregnant/breastfeeding women, history of eating disorders, Type 1 diabetics (risk of ketoacidosis). Consult physician if on medications.

4. Hormetic Stress: Heat Shock Proteins and Cold Adaptation

Hormesis: beneficial adaptation from low-dose stress. Heat and cold stress activate cellular defense mechanisms that improve resilience and longevity. Sauna protocol: 3 sessions per week, 85°C (185°F), 20 minutes per session. Physiological effects: Heat shock protein (HSP) upregulation—HSP70 and HSP90 refold damaged proteins, prevent protein aggregation (linked to Alzheimer's, Parkinson's), and improve cellular stress resistance. Cardiovascular benefits: Sauna use 4-7×/week reduces all-cause mortality 40% and cardiovascular disease death 50% vs 1×/week (University of Eastern Finland, 15-year follow-up, n=2,315). Mechanism: Increased heart rate (120-140 bpm during sauna = moderate cardio intensity), improved endothelial function, reduced systemic inflammation. Growth hormone spike: 20-min sauna increases GH 140% (single session), 16× baseline (repeated sessions over week). Cold plunge protocol: 3 sessions per week, 3°C (37°F), 3 minutes per session. Timing: Post-cardio (Zone 2 training), NOT post-strength training (cold blunts muscle protein synthesis, impairs hypertrophy). Physiological effects: Norepinephrine release (increases 200-300% during cold exposure), improves focus, mood, and metabolic rate. Brown fat activation—cold exposure recruits brown adipose tissue (BAT), increasing energy expenditure and glucose disposal. Mitochondrial biogenesis in BAT via UCP1 (uncoupling protein 1) activation. Clinical data: 11 weeks of daily cold showers (30-60 seconds, 10°C) reduced sick days 29% vs control group (Netherlands, n=3,018). Cold adaptation improves immune function via increased white blood cell production. Safety: Start with 30-60 second cold showers, progress to ice baths. Never exceed 10 minutes (hypothermia risk). Exit immediately if shivering becomes uncontrollable. Contraindications: Raynaud's disease, cold urticaria, cardiovascular disease without physician clearance.

5. HRV Optimization: The Longevity Biomarker

Heart Rate Variability (HRV) measures variation in time between heartbeats—higher HRV indicates better autonomic nervous system balance (parasympathetic dominance, "rest and digest" vs sympathetic "fight or flight"). HRV declines with age, chronic stress, poor sleep, and systemic inflammation. Higher HRV predicts lower mortality, better cardiovascular health, and greater resilience to stress. Target: Increase baseline HRV +10ms over 90 days. Baseline varies by age and sex: Age 25-35: 55-75ms (men), 60-80ms (women). Age 40-50: 40-60ms (men), 45-65ms (women). Age 60+: 30-50ms (men), 35-55ms (women). Measurement: Oura Ring (overnight HRV, most accurate—measured during deep sleep when stable), Garmin HRV Status (7-day rolling average, accounts for day-to-day variability), Whoop HRV (morning measurement, less stable than Oura). Interventions that increase HRV: Sleep optimization (8+ hours, deep sleep >90 min—see Deep Sleep Protocol), Zone 2 cardio (3-4×/week, improves vagal tone), meditation/breathwork (10 min daily box breathing: 4-sec inhale, 4-sec hold, 4-sec exhale, 4-sec hold), alcohol reduction (alcohol suppresses HRV for 3-5 nights post-consumption), omega-3 supplementation (2g EPA/DHA daily, reduces inflammation). What lowers HRV: Overtraining (HRV <60% baseline = mandatory rest day), poor sleep (<6 hours or Sleep Score <70), acute illness (HRV drops 20-40% during infection), chronic stress (elevated cortisol suppresses parasympathetic tone). Clinical significance: Every 10ms increase in HRV associated with 10% reduction in all-cause mortality (meta-analysis, n=44,000+). HRV is a real-time biomarker of physiological resilience—track it religiously.

6. Epigenetic Age Testing: Measuring Biological Age

Epigenetic clocks measure biological age via DNA methylation patterns—chemical modifications to DNA that change with age and lifestyle. Three primary clocks: Horvath Clock (multi-tissue age predictor, correlates with chronological age r=0.96), GrimAge (predicts time to death, strongest mortality predictor, includes blood protein biomarkers), PhenoAge (phenotypic age, predicts healthspan and disease risk). Testing companies: TruDiagnostic TruAge COMPLETE ($499, measures all three clocks + pace of aging + immune age), Elysium Index ($299, measures biological age via Horvath clock), myDNAge ($299, Horvath clock only, research-grade). Protocol: Test at baseline (before starting longevity interventions), re-test every 6-12 months to validate interventions. Sample collection: Finger prick blood spot (mail-in kit), results in 3-6 weeks. Interpreting results: Biological age < chronological age = good (e.g., 45-year-old with biological age 38 = 7 years younger). Biological age > chronological age = accelerated aging (e.g., 45-year-old with biological age 52 = intervention needed). Pace of aging: 1.0 = aging at normal rate, <1.0 = aging slower than peers, >1.0 = aging faster. Clinical data: Lifestyle interventions (diet, exercise, sleep, stress management) reduced biological age 1.96 years vs control over 8 weeks (GrimAge clock, Stanford, 2023). Metformin (500mg daily for 12 weeks) reduced biological age 2.4 years in adults with prediabetes (TruAge clock, n=120). Limitations: Clocks have ±2-3 year measurement error (noise), require consistent sample timing (morning fasted state), and show variability between test batches. Don't obsess over single test—focus on trends over 12+ months.

7. Bloodwork Biomarkers: Monthly Monitoring

Beyond epigenetic age, track metabolic and inflammatory biomarkers monthly (or quarterly minimum). HbA1c (glycated hemoglobin, 3-month glucose average): Target <5.5% (optimal metabolic health). 5.5-5.9% = prediabetes risk. >6.0% = diabetes screening needed. Intervention: CGM-guided diet (see Zone 2 + CGM protocol), time-restricted eating, resistance training. hsCRP (high-sensitivity C-reactive protein, systemic inflammation): Target <1.0 mg/L (low cardiovascular risk). 1.0-3.0 = moderate risk. >3.0 = high risk, investigate inflammation source. Intervention: Omega-3 2g daily (reduces hsCRP 20-30%), Zone 2 cardio (anti-inflammatory), eliminate processed foods. ApoB (apolipoprotein B, atherogenic particle count): Target <60 mg/dL (optimal), <80 mg/dL (acceptable). >100 mg/dL = elevated cardiovascular risk. More predictive than LDL-C. Intervention: Statins (if ApoB >130, physician-prescribed), omega-3, niacin (prescription if needed). Homocysteine (cardiovascular and cognitive risk marker): Target <7 μmol/L (optimal). >10 = elevated risk, >15 = high risk (stroke, dementia). Intervention: B-vitamin complex (folate, B6, B12), reduce methionine intake (red meat). Testing logistics: LabCorp or Quest walk-in (no doctor order needed in most states, $150-250 for full panel), or subscription services like InsideTracker ($299-599, includes analysis and recommendations). Frequency: Monthly if optimizing aggressively, quarterly if maintenance mode. Track trends, not single values—month-to-month variability is normal.

8. Resveratrol and Sirtuin Activation

Resveratrol is a polyphenol found in red wine, grapes, and berries, popularized for sirtuin activation (SIRT1 enzyme mimics caloric restriction effects). Mechanism: Resveratrol activates SIRT1, which deacetylates proteins involved in metabolism, inflammation, and DNA repair. Animal studies show lifespan extension 10-20% in yeast, worms, and mice. Human evidence is weaker—bioavailability is low (<1% oral absorption), and clinical trials show mixed results. Dosing: 500mg daily (far exceeding dietary intake from food). Take with NMN/NR in morning (synergy—resveratrol activates sirtuins, NAD+ fuels them). Forms: Trans-resveratrol (active form, confirm on label), micronized for better absorption. Clinical data: 12 weeks of resveratrol (150mg daily) improved insulin sensitivity and reduced liver fat in obese adults, but no longevity biomarker changes (Maastricht University, 2023). Meta-analysis of 20+ trials: Resveratrol shows cardiovascular benefits (reduced inflammation, improved endothelial function) but no consistent mortality reduction. Verdict: Possibly beneficial as SIRT1 activator, but evidence is weaker than NMN/NR. Include if budget allows ($20-40/month), but prioritize NAD+ precursors, omega-3, and metformin (if prescribed) first. Alternative: Fisetin (senolytic compound, clears senescent cells) 500mg daily, 2 days/month. Emerging evidence for anti-aging effects, but human trials limited.

9. Metformin: The Longevity Drug Hiding in Plain Sight

Metformin is a first-line Type 2 diabetes medication (FDA-approved 1994), but longevity researchers use it off-label for lifespan extension based on observational data showing diabetics on metformin live longer than non-diabetic controls—a paradox suggesting metformin provides benefits beyond glucose control. Mechanism: AMPK activation (cellular energy sensor, mimics fasting/exercise), mTOR inhibition (suppresses growth pathways, promotes autophagy), reduced hepatic glucose production (lowers insulin levels, improves insulin sensitivity), mitochondrial complex I inhibition (mild stress triggers hormetic adaptation). Clinical longevity evidence: TAME trial (Targeting Aging with Metformin, NIH-funded, ongoing, n=3,000, ages 65-79) testing whether metformin delays aging-related diseases. Preliminary observational data: Metformin users show 15% reduction in all-cause mortality vs non-users. Dosing: 500mg once or twice daily with meals (off-label longevity use, requires physician prescription). Extended-release (ER) formulation reduces GI side effects. Who should consider: Adults 40+ with elevated HbA1c (5.7-6.4%, prediabetes range), strong family history of diabetes, or seeking evidence-based longevity intervention. Who should NOT take: Type 1 diabetics (no insulin resistance to improve), kidney disease (metformin accumulates, risk of lactic acidosis), liver disease, history of lactic acidosis. Side effects: GI distress (nausea, diarrhea—30% of users, usually resolves after 2-4 weeks), B12 deficiency (metformin impairs absorption, supplement 1000mcg daily), rare: lactic acidosis (0.03 cases/1000 patient-years, mostly in kidney disease). Monitoring: HbA1c every 3-6 months (should decrease 0.3-0.5%), kidney function annually (creatinine, eGFR), B12 levels annually. Cost: Generic metformin $4-10/month (GoodRx), metformin ER $15-30/month. Requires prescription—discuss with physician as preventive longevity intervention.

10. Omega-3 Fatty Acids: Systemic Anti-Inflammatory

Omega-3 fatty acids (EPA and DHA) are essential polyunsaturated fats with broad anti-inflammatory, cardiovascular, and cognitive benefits. Mechanism: Incorporate into cell membranes (improve fluidity, signaling), produce anti-inflammatory mediators (resolvins, protectins via EPA/DHA metabolism), reduce pro-inflammatory cytokines (IL-6, TNF-α), improve endothelial function (nitric oxide production, vasodilation). Dosing: 2g combined EPA + DHA daily. Most people consume <300mg/day from diet (salmon, mackerel, sardines), requiring supplementation. Forms: Triglyceride form (natural, better absorption, look for "TG" or "rTG" on label), ethyl ester (cheaper but lower bioavailability, avoid). Brands: Nordic Naturals, Thorne, Carlson, OmegaVia (third-party tested for purity, no heavy metals/PCBs). Clinical data: Omega-3 supplementation (2g daily) reduces all-cause mortality 8%, cardiovascular mortality 17%, and heart attack risk 28% (meta-analysis of 13 RCTs, n=127,000). DHA specifically supports cognitive function—1g DHA daily slowed cognitive decline in mild Alzheimer's (6-month trial, USC). Omega-6:Omega-3 ratio: Western diet averages 15:1 (high omega-6 from seed oils promotes inflammation). Target 4:1 or lower. Reduce omega-6 (eliminate soybean, corn, sunflower oils), increase omega-3 (fatty fish 2-3×/week + supplement). Storage: Refrigerate fish oil (prevents oxidation), check expiration date (rancid fish oil is pro-inflammatory). Take with food (improves absorption, reduces fishy burps). Vegan alternative: Algae-based DHA/EPA (500mg-1g daily, lower EPA content than fish oil but suitable for plant-based diets).

11. Sample Daily Protocol: Timing and Sequencing

Morning (6:00-8:00 AM, fasted): 500mg NMN sublingual (hold under tongue 1 min) OR 1000mg NR oral. 500mg resveratrol with water. 200mg caffeine (black coffee, optional—enhances NAD+ precursor absorption). Delay breakfast 1-2 hours (maintain fasted state for NAD+ bioavailability). Breakfast (8:00-10:00 AM, breaking fast): Omega-3 2g (with meal containing fat for absorption). Vitamin D3 5000 IU (if supplementing—take with fat). Magnesium glycinate 200mg (if splitting daily dose, or take all 400mg before bed). Post-Workout (if training in AM): Protein 30-40g, carbs 40-60g (mTOR activation for muscle synthesis is beneficial post-exercise). Creatine 5g (if following strength protocol). Lunch (12:00-2:00 PM): Normal meal (protein, healthy fats, complex carbs). Vitamin B-complex (if taking metformin, prevents B12 deficiency). Dinner (6:00-8:00 PM, last meal of day): Metformin 500mg with food (if prescribed). Omega-3 2g if not taken at breakfast (split into 2 doses for better absorption). Zinc 30mg, magnesium glycinate 200mg (or full 400mg dose). Before Bed (9:00-10:00 PM): Review Oura HRV, Readiness Score. If HRV <60% baseline or Readiness <60, consider rest day tomorrow (overtraining indicator). Sauna/Cold Protocol (3× per week, any time): Sauna 20 min at 85°C, followed by cold plunge 3 min at 3°C. Do NOT cold plunge post-strength training (blunts hypertrophy). Monthly: 48-hour water fast (consume only water, electrolytes, black coffee—Friday 8 PM through Sunday 8 PM). Break fast with small protein + fat meal. Quarterly: Epigenetic age test, full bloodwork panel (HbA1c, hsCRP, ApoB, homocysteine). Adjust interventions based on trends.

12. Who Should Follow This Protocol

Ideal candidates: Adults 35-65 seeking evidence-based longevity interventions (younger individuals have less NAD+ decline, less benefit). High-stress professionals or executives (HRV optimization critical for performance). Individuals with family history of metabolic disease, cardiovascular disease, or Alzheimer's (proactive prevention). Biohackers willing to invest $300-500/month in supplements, testing, and tracking (hardware + chemistry + bloodwork). People comfortable with physician-supervised interventions (metformin requires prescription, bloodwork monitoring). Not recommended for: Individuals under 30 without metabolic dysfunction (NAD+ levels still high, interventions premature). People unwilling to track biomarkers (protocol requires data—Oura HRV, epigenetic testing, bloodwork—to validate efficacy). Budget-constrained users (<$200/month available—prioritize omega-3, sleep optimization, Zone 2 cardio first, skip NAD+ precursors and testing). Pregnant/breastfeeding women (safety data insufficient for NMN/NR, fasting contraindicated). Type 1 diabetics (metformin inappropriate, fasting risky without physician supervision). Clinical populations requiring physician involvement: Cardiovascular disease (sauna/cold exposure requires clearance), kidney/liver disease (metformin contraindicated), taking immunosuppressants (avoid rapamycin even if prescribed, drug interaction), history of eating disorders (fasting protocols inappropriate). This is an advanced protocol—consult physician before starting, especially if on medications or have chronic conditions.

13. The Bottom Line: Longevity Is a Marathon, Not a Sprint

The Longevity Biomarker Protocol synthesizes cutting-edge aging research into actionable interventions: NAD+ restoration via NMN/NR (500mg-1000mg daily), mTOR modulation via time-restricted eating and periodic fasting (16:8 IF + monthly 48-hour fast), hormetic stress via sauna and cold exposure (3×/week each), cardiovascular resilience via HRV tracking (target +10ms over 90 days), systemic inflammation reduction via omega-3 (2g daily), and optional metformin (500mg daily, physician-prescribed). Cost: $300-500/month (supplements + testing + hardware). Time commitment: 30 min daily (supplement timing + sauna/cold). Expected outcomes: Biological age reduction 1-3 years over 6-12 months (measured by epigenetic testing), HRV increase 10-15ms, improved metabolic biomarkers (HbA1c <5.5%, hsCRP <1.0, ApoB <80), enhanced subjective energy and recovery. This is not a quick fix—longevity optimization requires sustained commitment, continuous biomarker tracking, and willingness to adjust based on data. The interventions are evidence-based but still emerging science—clinical trials are ongoing (TAME for metformin, NAD+ precursor longevity trials). Approach as self-experimentation with physician oversight. Track HRV weekly, bloodwork quarterly, epigenetic age annually. If biomarkers don't improve after 6 months, reassess interventions (dose adjustments, eliminate non-responders, add missing elements like sleep or exercise). The goal is not immortality—it's maximizing healthspan, the years spent in peak physical and cognitive function. Build your longevity stack gradually: Start with omega-3 and sleep optimization (foundational, low-risk). Add NAD+ precursors and HRV tracking (Month 2-3). Incorporate sauna/cold and time-restricted eating (Month 4-6). Consider metformin and epigenetic testing (Month 6-12, with physician). Longevity is a long game. Consistency beats intensity. Start today.

◉ Chemistry Stack
1
NMN (or NR)
DOSE:500mg (or 1000mg NR)
TIMING:Morning, sublingual/oral
2
Resveratrol
DOSE:500mg
TIMING:Morning with NMN
3
Metformin (Rx)
DOSE:500mg
TIMING:Dinner (if prescribed)
4
Omega-3 (EPA/DHA)
DOSE:2g
TIMING:With largest meal
5
Vitamin D3
DOSE:5000 IU
TIMING:Morning with fat
6
Magnesium Glycinate
DOSE:400mg
TIMING:Before bed
Legal Disclaimer

Individual Results May Vary. The protocols, supplement recommendations, and expected outcomes presented on this page are based on available research and anecdotal reports. BioDataHQ makes no guarantees regarding specific results. Supplements are not evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Hardware recommendations are informational only — device accuracy, regulatory status, and feature availability vary by region. Some devices require subscriptions or additional costs not reflected in base pricing. Affiliate links present — we may earn commissions on purchases made through links on this page. This does not affect the objectivity of our analysis. Full affiliate disclosure.

Related Research